Skip to main content

Advertisement

Table 1 Tolvaptan challenge—response of plasma sodium concentration to tolvaptan therapy

From: Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma

Time 09.00 12.00 14.40 18.00 08.00 following day
Plasma Na + (mmol/L) 126 127 130 131 132